What did @liveoaktestosterone actually say?
The creator made a sweeping claim: "I have zero guys on estrogen blockers in the practice." The argument is that aromatase inhibitors (AIs) are a relic of bodybuilding culture, not legitimate medicine, and that standard TRT doses simply don't require them. He frames the whole estrogen-blocking conversation as a myth born from gym culture rather than clinical evidence.
That's a defensible starting position, but the way it's stated leaves almost no room for the patients who genuinely do need estrogen management. "Testosterone replacement therapy doses do not need aromatase inhibitors" is a broad generalization, and broad generalizations in hormone medicine tend to age poorly.
Does the science back this up?
Mostly, yes, but with important caveats. The creator is correct that routine AI use in TRT is not supported by current evidence and can cause real harm. The Endocrine Society's 2018 clinical practice guidelines do not recommend prophylactic estrogen suppression for men on TRT. Estradiol, converted from testosterone via aromatase, plays a role in bone density, cardiovascular health, libido, and mood in men. Suppressing it indiscriminately causes problems.
A 2016 study by Finkelstein et al. in the New England Journal of Medicine showed that blocking estrogen in testosterone-deficient men led to reduced bone density, increased fat mass, and decreased libido, effects often blamed on low testosterone alone. That study was a turning point in how clinicians think about male estradiol. But the same body of literature shows a subset of men, particularly those who are obese, have high aromatase activity, or have documented symptomatic hyperestrogenism, can benefit from targeted AI use. The "zero guys" claim doesn't leave room for that subset.
What did they get wrong (or right)?
They got the core message right. Routine, automatic AI prescribing alongside TRT is not evidence-based and is genuinely a holdover from bodybuilding practice where supraphysiologic testosterone doses drove estrogen into ranges that do cause gynecomastia. At standard replacement doses, most men won't hit those ranges.
Where the creator oversimplifies: estrogen response on TRT is not uniform. Body composition, genetics, and SHBG levels all influence how much a given man will aromatize. A lean 160-pound man and an obese 260-pound man on identical doses will have very different estradiol responses. Studies like Ramasamy et al. (2014, Journal of Urology) documented symptomatic hyperestrogenism in a subset of hypogonadal men that responded to AI therapy. Saying "zero guys" need this flattens real clinical variability. The claim that men will "cry at any little thing" from estrogen is also reductive and stigmatizing language that doesn't reflect how estrogen actually affects mood physiology in men.
What should you actually know?
If you're on TRT, you don't need an aromatase inhibitor unless your labs and symptoms actually warrant one. That's the defensible takeaway here. Estradiol is not your enemy. It supports bone health, cardiovascular function, and sexual health in men. Tanking it with an AI to hit some arbitrary "optimal" number is not good medicine.
However, some men do experience symptomatic high estrogen on TRT: persistent gynecomastia, significant water retention, or documented supraphysiologic estradiol levels. In those cases, targeted AI use under close monitoring can be appropriate. The decision should be driven by bloodwork and symptoms, not by a blanket policy in either direction. A 2021 review by Bhasin et al. in the New England Journal of Medicine reinforces that individualized management based on labs and clinical presentation remains the standard. One-size-fits-all rules, whether "everyone needs an AI" or "nobody needs an AI," don't serve patients well.